Pricing
Cheapest Tirzepatide Online: Every Price, With Its Evidence (2026)
There is no single cheapest tirzepatide, because the answer changes with commitment length, dose, and whether a membership is required.
There is no single cheapest tirzepatide, because the answer changes with commitment length, dose, and whether a membership is required. Compounded programmes run $69 to $299 a month all-in in our November 20, 2026 index, brand Zepbound is $299 to $449 direct, and coverage beats both — roughly $25 with a commercial plan, $50 on the Medicare GLP-1 Bridge. Below, each definition of cheapest is answered separately, with the read date on every figure.
Current prices, read October 15 and November 20, 2026
Market check, November 20, 2026: 28 compounded tirzepatide programs in our index run from $69 (a Black Friday sale price) to $299 a month all-in, median $144; 28 compounded semaglutide programs run $39 to $249, median $114. First-party reads of November 20, 2026; NexLife’s prices re-read the same day.
Cheapest compounded tirzepatide · November 9, 2026: the lowest all-in figure in our index is about $86 a month (Collective: $69 a month plus a $199 yearly membership, read October 15, 2026). WellMedr lists $89 on a fall sale and Mondae $114 on a 6-month plan or $126 month to month. NexLife, our #1 pick, lists $115 on a 12-month plan and $129 month to month (November 20, 2026); Eden’s $129 equals that month-to-month price.
| Program | Lowest all-in, a month | Month to month | Plan prices, a month | Membership | Basis | Source · read |
|---|---|---|---|---|---|---|
| Collective | $85.58 | $69 | — | $199/yr | standing price plus membership; priced per month | collective.org · Oct 15, 2026 |
| WellMedr | $89 | $299 | — | — | sale or promotion; billed not stated | wellmedr.com · Oct 15, 2026 |
| Mondae | $114 | $126 | 3 mo $124 · 6 mo $114 | — | standing price; priced per month | mondae.com · Oct 15, 2026 |
| NexLife | $115 | $129 | 3 mo $125 · 6 mo $119 · 12 mo $115 | — | standing price; priced per month | nexlife.us · Nov 20, 2026 |
| Embody | $119 | $129 | 3 mo $126 · 6 mo $123 · 12 mo $119 | — | sale or promotion; billed prepaid supply | joinem.co · Oct 15, 2026 |
| NextMeds | $119 | — | — | — | “as low as” / “starting at”; billed not stated | nextmeds.com · Oct 15, 2026 |
| SnagRx | $119 | $119 | — | — | sale or promotion; priced per month | snagrx.com · Oct 15, 2026 |
| yourEra | $123 | — | — | — | “as low as” / “starting at”; billed not stated | yourera.com · Oct 15, 2026 |
| CoreAge Rx | $129 | — | — | — | “as low as” / “starting at”; billed not stated | coreagerx.com · Oct 15, 2026 |
| Eden | $129 | $129 | — | — | standing price; priced per month | eden.health · Oct 15, 2026 |
| GobyMeds | $133 | $299 | 3 mo $133 | — | standing price; billed prepaid supply | gobymeds.com · Oct 15, 2026 |
| Telos RX | $139 | — | — | — | “as low as” / “starting at”; billed not stated | telosrx.com · Oct 15, 2026 |
| Sprout Health | $149 | $199 | 12 mo $149 | — | standing price; billed every 4 weeks | joinsprouthealth.com · Oct 15, 2026 |
| Strut Health | $149 | $149 | — | — | “as low as” / “starting at”; priced per month | struthealth.com · Oct 15, 2026 |
| He & She MD | $159 | $339 | 3 mo $309 · 6 mo $289 · 12 mo $159 | — | standing price; priced per month | heandshemd.com · Oct 15, 2026 |
| Bodybuilding Health+ | $174.67 | $209 | 3 mo $179 · 6 mo $174.67 · 12 mo $187.33 | — | standing price; billed term not stated | bbhealthplus.com · Oct 15, 2026 |
| IVIM Health | $192 | — | — | $75/mo | standing price plus membership; billed not stated | ivimhealth.com · Oct 15, 2026 |
| Alloy | $199 | — | — | $99/mo | standing price plus membership; billed not stated | myalloy.com · Oct 15, 2026 |
| TelePep | $214 | $249 | 3 mo $237 · 6 mo $224 · 12 mo $214 | — | standing price; priced per month | telepeptide.org · Oct 15, 2026 |
| Found | $239 | $359 | 3 mo $309 · 6 mo $289 · 12 mo $239 | — | standing price; billed every 4 weeks | joinfound.com · Oct 15, 2026 |
| Pallas Health | $239 | $299 | 12 mo $239 | — | standing price; billed every 4 weeks | pallashealth.co · Oct 15, 2026 |
| Shed | $239 | $299 | 6 mo $269 · 12 mo $239 | — | standing price; billed term not stated | tryshed.com · Oct 15, 2026 |
| Enhance.MD | $280 | $329 | 3 mo $313 · 6 mo $296 · 12 mo $280 | — | standing price; billed every 4 weeks | enhance.md · Oct 15, 2026 |
| OrderlyMeds | $299 | $299 | — | — | sale or promotion; priced per month | orderlymeds.com · Oct 15, 2026 |
| Program | July 2026 record | Current read | Change |
|---|---|---|---|
| Found, tirzepatide | $359 month to month; $239 on 12 months (cash, per 28-day cycle) | $339 month to month; $199 on 12 months | Lower |
| Strut Health, tirzepatide | $149 a month | $219 a month (now with glycine) | Higher |
| WellMedr, tirzepatide | $89 on a fall sale | $69 on a Black Friday sale | Lower (sale) |
| yourEra, tirzepatide | “as low as” $123 | $186 month to month, $134 on 6 months (Black Friday prices) | Now priced by plan |
| Zappy Health, tirzepatide | no tirzepatide price in our index | $299 month to month, $259 on 6 months (read November 21; $349 / $299 on November 20) | Added |
| TelePep, semaglutide | $199 month to month; $169 on 12 months | $149 month to month; $119 on 12 months | Lower |
| Noom Med, semaglutide | $279 a month | $249 a month (its product page still says $279) | Lower, conflicting |
| NextMeds, tirzepatide | “as low as” $119 | no tirzepatide price printed | Dropped from the index |
| Added to the index | — | bmiMD, Yucca Health, Lavender Sky Health, Mochi Health, Fifty 410, Zappy Health, Noom Med (tirzepatide); Henry Meds (semaglutide) | Added |
| Not re-read | — | Embody and He & She MD keep their October 15 rows and are left out of the statistics; Enhance.MD’s semaglutide row is dropped | Carried or dropped |
| NexLife | $129 / $115 tirzepatide; $109 / $95 semaglutide (from November 6) | unchanged; NexLife now says 3-, 6- and 12-month plans are paid upfront | No price change |
Answer by definition, because “cheapest” is five different questions
Most rankings publish one number. That number is almost always the advertised entry price on the longest prepaid plan, which is the least representative figure available. Here is each definition answered separately.
Cheapest month-to-month, no commitment. On October 15, 2026, Mondae listed $126 a month standing; Eden and NexLife both charge $129 (NexLife as of November 20, 2026). WellMedr’s $89 is a sale price.
Cheapest on a multi-month plan. Mondae at $114 a month on a 6-month plan (October 15, 2026). For reference, NexLife lists $115 a month on a 12-month plan (November 20, 2026), and Embody $119 on a prepaid year (sale, October 15, 2026).
Cheapest with a membership counted. Collective at $69 a month plus a $199 yearly membership, about $86 a month all-in, with the same price at any dose (October 15, 2026). NexLife charges the same at every dose with no membership: $129 month to month, $115 on twelve months. A price that holds through dose escalation matters most, because it is the only price that survives a move to a maintenance dose.
Microdose programmes. NexLife’s microdose now costs the same as its standard plan ($95 a month for semaglutide and $115 for tirzepatide on 12 months, November 20, 2026); in our July 2026 records other microdose programmes ran $149 to $349. A microdose is a dose below anything the trials studied: treat it as a different treatment rather than a discount — see the microdose page.
Cheapest FDA-approved route. Zepbound at $299 a month direct from LillyDirect at the starter dose, rising to $449. The cheapest approved GLP-1 of any molecule is $149.
Cheapest overall, any route. Insurance. A covered brand can land near $25 a month; eligible Medicare enrollees pay $50 through the GLP-1 Bridge until 31 December 2027. Both beat every cash price on this page, and most people never check.
The five things that make a cheap price expensive
These are the mechanisms that separate an advertised figure from what you actually pay. For each, we name which providers in our dataset do it.
1. Membership stacking
A low medication price with a separate required fee on top. In our dataset memberships run from $19.99 to $149 a month: PlushCare $19.99, WeightWatchers Clinic $74, Mochi Health $79, Eden $99, and Hims, Hers and Ro all at $149.
At the top of that range the membership can equal the medication. Hims and Hers charge $149 for the oral Wegovy tablet plus $149 membership — a product NovoCare sells direct for $149 with no membership at all.
No separate membership: NexLife (opens nexlife.us in a new tab) (captured), plus Oak Longevity, TrimRx, Found, Henry Meds and Sprout Health on a provider-reported basis.
2. Dose-escalation pricing — the dose tax
The label directs 2.5 mg for four weeks, then 5 mg, then increases in 2.5 mg increments no sooner than every four weeks, to a maximum of 15 mg. It names 5, 10 and 15 mg as the recommended maintenance dosages and states that 2.5 mg is not approved as a maintenance dosage.
So an advertised entry price describes four weeks of a treatment you will take for years.
Escalates: LillyDirect ($299 → $399 → $449 by dose), Shed, and MEDVi (reported to reach $499 at maintenance doses).
Holds price at every covered dose: NexLife (opens nexlife.us in a new tab) (captured), plus Oak Longevity, TrimRx, Mochi Health, Eden, Enhance.MD and Found on a provider-reported basis.
3. Introductory versus ongoing rate
Eleven programmes in our dataset advertise a discounted first month. Hims, Hers and Mochi Health at $39; WeightWatchers Clinic at $25; PlushCare free on some plans; Enhance.MD at $112 rolling to $212.
Every one is excluded from every ranking on this site. A first-month rate applies to one month of an indefinite treatment.
4. Prepayment and what it puts at risk
The lowest advertised rates usually need a multi-month plan or a sale. Found listed $359 for a single 28-day cycle against $239 per cycle on its longest plan on October 15, 2026, a 50% premium for flexibility. NexLife is $129 against $115, a 12% premium.
Two risks belong with a twelve-month commitment. In SURMOUNT-1, 4.3% to 7.1% of participants discontinued because of adverse events depending on dose — you are committing before you know whether you tolerate it. And the FDA has proposed excluding tirzepatide from the 503B bulks list, with the comment period closed 30 July 2026 and no determination published.
Get the refund position for a regulatory interruption in writing before prepaying. Almost no provider publishes it.
5. What the price does not include
Laboratory work is the field we most often cannot establish from a published page. Shipping, consultation and supplies are usually included in compounded programmes and usually stated; labs frequently are not.
Ask specifically: are labs required, are they included, or are they billed to me or my insurance?
What our figures mean, and what they do not
Every price on this site carries an evidence status and a date. The current index re-reads 28 compounded tirzepatide programs from their own pages as of October 15, 2026; NexLife’s figures come from its plan pages of November 20, 2026.
The remaining 48 are provider-reported: stated by a provider or a third-party dataset, not checked by us. They may be perfectly accurate. Nobody here has confirmed them, and we will not describe an unchecked number as verified because another site published it.
That is a smaller verified count than some competitors publish, and we would rather show the real number than inflate it. The capture programme is running; the count will rise.
Where NexLife actually ranks
NexLife is not the cheapest advertised price. Programmes advertise entry rates from around $86 in our October 15, 2026 index. NexLife is $129 month to month, falling to $125 on three months, $119 on six and $115 on twelve (November 20, 2026).
What distinguishes it is that the price does not change as the dose rises, there is no membership fee, and its plan pages name the 503A pharmacies that fill its prescriptions. If you titrate to a maintenance dose — which the label expects — a flat rate is frequently cheaper across a year than a lower advertised rate that escalates.
Where a competitor is cheaper we publish it: on October 15, 2026, Collective (about $86 all-in with membership), WellMedr ($89, sale) and Mondae ($114 on 6 months, $126 month to month) listed lower figures than NexLife, and Eden’s $129 equals NexLife’s month-to-month price.
Compounded against approved, honestly
Compounded tirzepatide is not FDA-approved. It has not been reviewed for safety, effectiveness or manufacturing quality, it is not a generic, and no trial has studied any compounded preparation. The SURMOUNT figures quoted across this market come from trials of the approved product at studied doses.
That is not an argument against it. It is the trade being made, and it should be made knowingly. Brand Zepbound at $299 direct is now close enough to the upper half of the compounded market that the trade is worth re-running — sixteen compounded offerings in our dataset cost more than $299.
Before you pay anyone
- Check insurance first. It beats every route on this page.
- Ask what you pay at 10 mg, not at the starting dose.
- Ask which pharmacy fills the prescription and whether it is 503A or 503B. No provider in our dataset has told us.
- Ask whether labs are required and included.
- Get the refund position in writing before prepaying anything.
| Measure | Figure | What it measures | Source |
|---|---|---|---|
| Efficacy estimand, 15 mg | 22.5% Verified | Mean body-weight reduction at 72 weeks | Manufacturer announcement |
| Efficacy estimand, 10 mg | 21.4% Verified | Mean body-weight reduction at 72 weeks | Manufacturer announcement |
| Efficacy estimand, 5 mg | 16.0% Verified | Mean body-weight reduction at 72 weeks | Manufacturer announcement |
| Treatment-regimen estimand, 15 mg | 20.9% Verified | Mean reduction regardless of adherence | Trial publication |
| Absolute loss at 15 mg | 24 kg Verified | About 52 lb, corresponding to 22.5% | Manufacturer announcement |
| Median time to weight plateau | 24.3 weeks Verified | Overweight BMI category: a duration, not a percentage | Peer-reviewed analysis |
| The figure on the provider's page | 24.3% Outdated | Stated as body-weight reduction in SURMOUNT-1 | Provider's own page |
| Definition of cheapest | Lowest we hold | Program | Basis | Source · read |
|---|---|---|---|---|
| Lowest all-in, membership counted | $85.58/mo | Collective | $69 a month plus a $199 yearly membership | collective.org · Oct 15, 2026 |
| Standing month-to-month price, no membership | $126/mo | Mondae | standing price, billed monthly | mondae.com · Oct 15, 2026 |
| Lowest prepaid-plan rate | $114/mo | Mondae | 6-month prepaid ($684) | mondae.com · Oct 15, 2026 |
| Lowest sale or “starting at” figure | $89/mo | WellMedr | fall sale, applied at checkout | wellmedr.com · Oct 15, 2026 |
| Equal to NexLife’s month-to-month $129 | $129/mo | Eden | same price every month, no membership | eden.health · Oct 15, 2026 |
| FDA-approved, lowest self-pay dose | $149/mo | Foundayo 0.8 mg (LillyDirect); Wegovy pill 1.5 mg (NovoCare) | brand self-pay, lowest dose only | lilly.com · novocare.com · Oct 15, 2026 |
| Provider | Lowest reported | Highest reported | Spread | Publishers | What the gap actually is |
|---|---|---|---|---|---|
| Found | $169 | $497 | $328 | 2 | 12-month prepaid against membership-plus-medication total |
| bmiMD | $139 | $399 | $260 | 2 | 12-month tier against standard ongoing rate |
| Oak Longevity | $130 | $285 | $155 | 2 | Starter dose against 1-month plan, escalates per step |
| Enhance.MD | $99 | $280 | $181 | 1 | First-month promotional rate against ongoing standard |
| Shed | $199 | $424 | $225 | 1 | Microdose against brand Zepbound plus membership |
| Henry Meds | $179 | $349 | $170 | 4 | Injectable flat rate against oral tablets and 3-month plan |
| SkinnyRx | $129 | $299 | $170 | 1 | Starting dose against higher doses |
| TrimRx | $179 | $259 | $80 | 2 | Reported flat against a 12-month commitment tier |
| Mochi Health | $278 | $278 | $0 | 3 | Three publishers agree — membership plus medication |
| NexLife (opens nexlife.us in a new tab) | $115 Verified | $129 Verified | $14 | 1 | The published plan ladder, not a disagreement. Same price at every dose |
| Programme | Monthly | Term | Evidence |
|---|---|---|---|
| NexLife (opens nexlife.us in a new tab) microdose | $115 Verified | 12-month plan | Verified Verified |
| NexLife (opens nexlife.us in a new tab) microdose | $129 Verified | Month-to-month | Verified Verified |
| Gala GLP-1 | $149 | Not stated | Provider-reported Provider-reported |
| Enhance.MD | $169 | 12-month plan, $99 first month | Provider-reported Provider-reported |
| Shed | $199 | 12-month plan | Provider-reported Provider-reported |
| bmiMD | $349 | Not stated | Provider-reported Provider-reported |
| Provider | Advertised | What the figure describes | Price at a maintenance dose |
|---|---|---|---|
| Embody | from $99 | Introductory starter rate | not verified |
| SkinnyRx | about $129 | Reported monthly figure, term not stated | not verified |
| Lavender Sky Health | about $129 | Starter dose; increases reported at higher doses | not verified |
| Oak Longevity | about $130 | Reported monthly figure | not verified |
| Fifty 410 | about $133 | 3-month package; higher doses reported to increase | not verified |
| Yucca Health | about $146 | Reported monthly figure, term not stated | not verified |
| TrimRx | about $179 | Reported monthly figure | not verified |
| Henry Meds | $179 to $297 | Varies by plan and formulation | not verified |
| NexLife | $115 to $129 Verified | Flat across covered doses, no membership | $115 to $129 Verified |
| OrderlyMeds | not verified | No obtainable published figure | not verified |
| Mechanism | What it does | Who does it, in our dataset |
|---|---|---|
| Membership stacking | A separate required fee on top of medication | PlushCare $19.99 · WeightWatchers $74 · Mochi $79 · Eden $99 · Hims, Hers, Ro $149 |
| Dose-escalation pricing | Price rises as the dose is titrated up | LillyDirect $299→$449 · Shed · MEDVi reported to $499 |
| Introductory rate | A first-month price that reverts | 11 programmes; all excluded from every ranking here |
| Prepayment requirement | Lowest rate needs a full term upfront | Found $169 prepaid vs $289 monthly (71%, July 2026) · NexLife $115 vs $129 (12%, November 2026) |
| Undisclosed inclusions | Labs, in particular, frequently unstated | Not captured for most providers Verification pending |
| Publisher | Figure published | What it appears to describe |
|---|---|---|
| GLP-1 Editorial | $369/mo | Starting and maintenance, described as flat |
| RxPepsDirect | $179/mo | Flat all-inclusive bundle: medication, visits, supplies, shipping |
| Forbes Health | from $297/mo | Oral tirzepatide tablets |
| Forbes Health, pricing table | from $179/mo | Compounded medication cost |
| RangeYourself | $179/mo | All-in, medication included |
| This publication | Provider-reported Provider-reported | We hold a provider-reported figure and no capture of our own |
| Route | At the starting dose | At a maintenance dose | Twelve months | Evidence |
|---|---|---|---|---|
| Flat-rate compounded, 12-month plan | $115 | $115 | $1,380 | Verified Verified |
| Flat-rate compounded, month-to-month | $129 | $129 | $1,548 | Verified Verified |
| Flat-rate compounded, microdose | $115 | $115 | $1,380 | Verified Verified |
| Reported flat all-inclusive bundle | $179 | $179 | $2,148 | Provider-reported Provider-reported |
| Medication plus required membership | $278 | $278 | $3,336 | Provider-reported Provider-reported |
| Dose-tiered programme, low advertised entry | $129 | $299–$499 | $3,500–$5,400 | Provider-reported Provider-reported |
| Approved oral GLP-1, held at a low dose | $149 | $149 | $1,788 | Verified Verified |
| Brand Zepbound following the label | $299 | $449 | $5,188 | Verified Verified |
| Medicare GLP-1 Bridge, if eligible | $50 | $50 | $600 | Provider-reported Provider-reported |
| Commercial coverage, typical copay | $25 | $25 | $300 | Provider-reported Provider-reported |
| Step | What the label says | Status |
|---|---|---|
| Starting dosage | 2.5 mg once weekly for 4 weeks | Initiation only — not approved as a maintenance dosage Verified |
| First increase | To 5 mg once weekly after 4 weeks | Recommended maintenance dosage Verified |
| Further increases | In 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and response | A minimum interval, not a fixed calendar Verified |
| 7.5 mg and 12.5 mg | Available strengths used during titration | Titration steps, not recommended maintenance dosages Verified |
| 10 mg | Once weekly | Recommended maintenance dosage Verified |
| 15 mg | Once weekly | Recommended maintenance dosage and the maximum Verified |
| Above 15 mg | No approved dosage exists | Verified Verified |
| Provider and programme | Advertised monthly | At 10 mg | Twelve months | Dose structure |
|---|---|---|---|---|
| Embody — compounded injectable | $99 | not verified | not verified | not verified |
| SkinnyRx — compounded injectable | $129 | not verified | not verified | not verified |
| Lavender Sky Health — compounded injectable | $129 | not verified | not verified | not verified |
| Fifty 410 — compounded injectable | $133 | not verified | not verified | not verified |
| Yucca Health — compounded injectable | $146 | not verified | not verified | not verified |
| NexLife (opens nexlife.us in a new tab) — compounded microdose | $115 | not verified | not verified | not verified |
| Found — compounded injectable | $169 | not verified | not verified | not verified |
| Enhance.MD — compounded microdose | $169 | not verified | not verified | not verified |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $115 | not verified | not verified | not verified |
| NexLife (opens nexlife.us in a new tab) — compounded microdose | $129 | $129 Verification pending | $1,548 Verification pending | Flat at every dose Provider-reported |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $119 | $119 Verified | $1,428 Verification pending | Flat at every dose Verified |
| NexLife (opens nexlife.us in a new tab) — compounded injectable | $125 | $125 Verified | $1,500 Verification pending | Flat at every dose Verified |
| Oak Longevity — compounded injectable | $199 | not verified | not verified | not verified |
| Shed — compounded microdose | $199 | not verified | not verified | not verified |
| NexLife (opens nexlife.us in a new tab) — compounded oral / ODT | $199 | not verified | not verified | not verified |
| NexLife — compounded injectable | $129 | $129 Verified | $1,548 Verification pending | Flat at every dose Verified |
Show this figure as a table
| Item | Twelve-month total | Evidence |
|---|---|---|
| Flat compounded, 12-month plan | $1,380 | Verified |
| Flat compounded, month-to-month | $1,548 | Verified |
| Approved oral held at a low dose | $1,788 | Verified |
| Brand Zepbound following the label | $5,188 | Verified |
| Medicare GLP-1 Bridge, if eligible | $600 | Verified |
| Commercial coverage, typical copay | $300 | Provider-reported |
| Price type | Meaning |
|---|---|
| Recurring | The ongoing monthly rate with no term commitment |
| Commitment tier | Requires a multi-month term, often paid upfront |
| Limited-time promo | A time-limited offer that will revert |
| Advertised starting price | A 'from' or 'starting at' figure, usually the entry dose |
| Range | Provider publishes a band rather than a single figure |
| Membership plus medication | Two charges; the all-in figure combines them |
| Intake-gated | No obtainable public price |
| Program type | What it covers | Comparable with |
|---|---|---|
| Starter program | Introductory period, often lower doses | Other starter programs only |
| Ongoing program | Standard continuing supply | Other ongoing programs only |
| Maintenance program | Post-titration supply, often a fixed dose | Other maintenance programs only |
| Prepaid term | Several months paid upfront | Monthly plans only after conversion |
| Month-to-month | Cancellable each cycle | Other month-to-month plans only |
| Microdose program | Sub-therapeutic dosing outside trial evidence | Other microdose programs only |
64 captured records across 23 providers, ranging $99 to $2048 a month all-in. 9 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.
Questions readers actually ask
What is the cheapest tirzepatide online in 2026?
It depends which definition you mean. Lowest standing month-to-month is Mondae at $126 (November 20, 2026); lowest all-in with a membership counted is Collective at about $86; NexLife charges $129 month to month and $115 on 12 months; the cheapest FDA-approved tirzepatide is Zepbound at $299 direct. Insurance beats all of them at roughly $25.
Why do other sites list tirzepatide at $99 a month?
Those are usually advertised entry prices on long prepaid plans, and many escalate as the dose rises. The label states 2.5 mg is initiation and not a maintenance dosage, so an entry price describes four weeks.
Is compounded tirzepatide legal?
Compounding by a licensed pharmacy against a valid prescription operates under section 503A. The FDA has proposed excluding tirzepatide from the separate 503B bulks list; no final determination has published.
How much is tirzepatide without insurance?
Compounded programmes run $69 to $299 a month all-in in our November 20, 2026 index. Brand Zepbound is $299 to $449 direct from LillyDirect. Approved oral GLP-1s start at $149, though they are different molecules.
Which providers charge the same price at every dose?
In our November 20, 2026 index, NexLife, Eden, Mondae, Yucca Health, Collective, WellMedr, Strut Health and Zappy Health print one price at every dose of compounded tirzepatide; Mochi Health and Lavender Sky Health price by dose. Confirm the price at your dose before you pay.
Should I prepay for twelve months to get the lowest rate?
It saves 16% to 71% depending on provider, and commits you before you know whether you tolerate the medication. Roughly one in fourteen participants at the top dose in SURMOUNT-1 discontinued for adverse events. Get the refund terms in writing.
Related on this site
- Provider ranking methodologyCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- Compounded vs Brand Tirzepatide: Legal and Evidence DifferencesJournal
- Compounded Tirzepatide Online: Legal, Safety and Cost GuidePillar / Money
- Cheapest Compounded Tirzepatide: Ongoing Costs ComparedPillar / Money
- Provider and Study Source LedgerData
- Open GLP-1 Data and Evidence LibraryData
- GLP-1 Tirzepatide Review: Evidence, Prices, Providers & ToolsCore & Trust
- Mochi Health vs Henry MedsComparisons
Related coverage
- Compare Tirzepatide Providers Side by Side
- What you pay at a maintenance dose
- GLP-1 Side Effects: What Is Expected and What Needs a Clinician
- GLP-1 Without Needles (2026): Pills, Lozenges and Drops Compared
- Hunger Comes Back Before My Next Dose: What That Usually Means
- GLP-1 Insurance Coverage: What Plans Actually Do, and How to Find Out Fast
- Appealing a GLP-1 Denial: The Four Levels and What Wins at Each
- When Your Plan Drops GLP-1 Coverage: What Changes and What You Can Do
- GLP-1 Prior Authorization: What Plans Ask For and How to Prepare
GLP-1 Tirzepatide Review. “Cheapest Tirzepatide Online: Every Price, With Its Evidence (2026).” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/tirzepatide/cheapest/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.